Suspected Severe Hypocalcemia
Corrected calcium <7.5 mg/dL (<1.9 mmol/L) or symptomatic
All Pathways
EndocrinologyEmergency
Severe Hypocalcemia Management
Severe Hypocalcemia Management: Suspected Severe Hypocalcemia → Recognize Clinical Features → Severity Assessment → SEVERE: IV Calcium Replacement → Con...
Pathway Overview
14 steps
Algorithm Steps
14 total
01Start 02Action Recognize Clinical Features
Neuromuscular irritability predominates
- Perioral/fingertip paresthesias
- Tetany (carpopedal spasm, laryngospasm)
- Chvostek sign: facial twitch on tapping
- Trousseau sign: carpal spasm with BP cuff
- Seizures
- Prolonged QTc, arrhythmias
- Hypotension, heart failure
03Decision Severity Assessment
Symptoms guide urgency
- SEVERE/SYMPTOMATIC: Tetany, seizures, arrhythmias, laryngospasm
- MODERATE: Paresthesias, muscle cramps, positive Chvostek/Trousseau
- MILD/ASYMPTOMATIC: Incidental finding, Ca 7.5-8.0 mg/dL
04Action SEVERE: IV Calcium Replacement
Emergency treatment
- Calcium gluconate 10%: 1-2 ampules (10-20 mL) IV over 10 min
- = 93-186 mg elemental calcium
- Dilute in 50-100 mL D5W or NS
- Cardiac monitoring during infusion
- Then: Continuous infusion 1-2 mg/kg/hr elemental Ca
05Action Continuous Calcium Infusion
After initial bolus for severe cases
- Calcium gluconate: 10 ampules (100 mL) in 1L D5W
- Infuse at 50-100 mL/hr (0.5-1 mg/kg/hr elemental)
- Target: Corrected Ca 8.0-9.0 mg/dL
- Do NOT add to bicarbonate-containing solutions
- Peripheral line OK, but check for infiltration
06Action Identify Underlying Cause
Guide long-term management
- Post-thyroidectomy/parathyroidectomy: Transient or permanent hypoparathyroidism
- Vitamin D deficiency: Check 25-OH vitamin D
- Hypomagnesemia: Alcoholism, diuretics, malabsorption
- Chronic kidney disease: Check PTH, phosphorus
- Pancreatitis: Saponification of calcium
- Medications: Bisphosphonates, denosumab, cinacalcet
07Warning ⚠️ Digoxin Caution
Risk of digoxin toxicity
- Calcium increases digoxin toxicity risk
- Slow calcium infusion if on digoxin
- Cardiac monitoring mandatory
- Consider lower infusion rates
08Action Monitoring
Close follow-up during treatment
- Ionized or corrected calcium q4-6h
- Magnesium level
- Continuous ECG during IV infusion
- Phosphorus (avoid hypercalcemia if high phosphorus → calcification)
- Symptoms (paresthesias, tetany)
09Action Transition to Oral Therapy
When calcium stable >8.0 mg/dL
- Oral calcium carbonate 1-3 g TID with meals
- Calcitriol 0.25-1 mcg/day (active vitamin D)
- Cholecalciferol if vitamin D deficient
- Overlap IV and oral before stopping IV
- Follow-up labs in 1-2 weeks
10Outcome Calcium Normalized
Continue oral supplements, address cause
11Warning Chronic Hypoparathyroidism
Long-term management needed
- Lifelong calcium + calcitriol
- Target: Low-normal calcium (avoid hypercalciuria)
- Monitor for nephrocalcinosis/nephrolithiasis
- Consider PTH replacement (natpara) in refractory cases
12Action Check & Correct Magnesium
CRITICAL: Hypocalcemia won't correct if Mg low
- Mg <1.0 mg/dL: MgSO4 2g IV over 10-20 min, then infusion
- Mg 1.0-1.5 mg/dL: MgSO4 1-2g IV over 1 hour
- Oral: Mg oxide 400-800 mg daily
- Hypomagnesemia causes PTH resistance
- Path rejoins step 06Shared downstream outcome
13Action MODERATE: IV/Oral Calcium
Less urgent replacement
- IV: Calcium gluconate infusion (slower rate)
- OR Oral: Calcium carbonate 1-3 g TID with meals
- Add calcitriol 0.25-0.5 mcg BID
- Check and correct magnesium
- Path rejoins step 12Shared downstream outcome
14Action MILD: Oral Calcium + Vitamin D
Outpatient management
- Oral calcium 1-3 g/day in divided doses
- Vitamin D or calcitriol
- Recheck in 1-2 weeks
- Identify underlying cause
- Path rejoins step 08Shared downstream outcome
Guideline Source
Acute Hypocalcemia Management: Society for Endocrinology Emergency Guidance
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Must correct hypomagnesemia for calcium to normalize
- Calcium gluconate preferred over calcium chloride (less tissue necrosis)
- Does not address neonatal hypocalcemia
- Digoxin toxicity risk with rapid calcium infusion
Applicable Regions
USEUUK
UK: Society for Endocrinology guidance
US: Similar principles apply
Version 1Next review: 2027-01-01
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Severe Hypocalcemia Management?
The Severe Hypocalcemia Management is a emergency clinical algorithm for Endocrinology. It provides a structured decision tree to guide clinical decision-making, based on Acute Hypocalcemia Management: Society for Endocrinology Emergency Guidance.
What guideline is the Severe Hypocalcemia Management based on?
This algorithm is based on Acute Hypocalcemia Management: Society for Endocrinology Emergency Guidance (DOI: 10.1530/EC-16-0056).
What are the limitations of the Severe Hypocalcemia Management?
Known limitations include: Must correct hypomagnesemia for calcium to normalize; Calcium gluconate preferred over calcium chloride (less tissue necrosis); Does not address neonatal hypocalcemia; Digoxin toxicity risk with rapid calcium infusion. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Severe Hypocalcemia Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free